CORONA, CA, Mar 02, 2009 (MARKET WIRE via COMTEX) -- Watson Pharmaceuticals, Inc. (NYSE: WPI), a leading specialty
pharmaceutical company, announced today that Paul Bisaro, Watson's
president and chief executive officer, will provide an overview and
update of the Company's business at the Barclays Capital Global
Healthcare Conference on Tuesday, March 10, 2009 at 9:30 a.m. Eastern
This presentation will be webcast live and can be accessed on Watson
Investor Relations Web site at http://ir.watson.com.
The webcast can also be accessed at the following URL:
An archived version will be available for 30 days after the live
presentation and can be accessed at the same locations.
About Watson Pharmaceuticals, Inc.
Watson Pharmaceuticals, Inc. is a leading specialty pharmaceutical
company that develops, manufactures, markets, sells and distributes
generic and specialty brand pharmaceutical products. Watson pursues a
growth strategy combining internal product development, strategic
alliances and collaborations and synergistic acquisitions of products
For press releases and other company information, visit Watson
Pharmaceuticals' Web site at http://www.watson.com.
Watson Pharmaceuticals, Inc.
SOURCE: Watson Pharmaceuticals